Beer Sheva, Israel

Leonid Metsger


 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Leonid Metsger: Innovator in Pharmaceutical Chemistry

Introduction

Leonid Metsger is a notable inventor based in Beer Sheva, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new crystalline forms of febuxostat. With a total of six patents to his name, Metsger's work has had a meaningful impact on the management of hyperuricemia in patients suffering from gout.

Latest Patents

Metsger's latest patents focus on the crystalline forms of febuxostat. These new forms have been prepared and characterized, showcasing their utility in the chronic management of hyperuricemia. The innovative approaches taken by Metsger in this area highlight his commitment to improving patient outcomes through advanced pharmaceutical solutions.

Career Highlights

Throughout his career, Leonid Metsger has worked with prominent companies in the pharmaceutical industry, including Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals USA, Inc. His experience in these organizations has allowed him to develop and refine his expertise in drug formulation and patent development.

Collaborations

Metsger has collaborated with talented professionals in his field, including Slavik Yurkovski and Maytal Piran. These partnerships have contributed to the successful development of his patented innovations.

Conclusion

Leonid Metsger's contributions to pharmaceutical chemistry, particularly through his patents on febuxostat, demonstrate his dedication to advancing medical treatments. His work continues to influence the management of gout and hyperuricemia, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…